97 related articles for article (PubMed ID: 1981694)
1. Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2810-3. PubMed ID: 1981694
[TBL] [Abstract][Full Text] [Related]
2. [Gastrointestinal absorption of nitrofurantoin: evaluation of a newly developed method for determination of the gastrointestinal transit time in dogs].
Mizuta H; Kawazoe Y; Ikeda Y; Ogawa K
Yakugaku Zasshi; 1991 Dec; 111(12):794-9. PubMed ID: 1806662
[TBL] [Abstract][Full Text] [Related]
3. Effect of small intestinal transit time on gastrointestinal absorption of 2-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl ] ethyl acetate, a new non-steroidal anti-inflammatory agent.
Mizuta H; Kawazoe Y; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2825-8. PubMed ID: 2076568
[TBL] [Abstract][Full Text] [Related]
4. Effects of meals on gastric emptying and small intestinal transit times of a suspension in the beagle dog assessed using acetaminophen and salicylazosulfapyridine as markers.
Mizuta H; Kawazoe Y; Haga K; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2224-7. PubMed ID: 1980638
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the phasic period of interdigestive migrating contraction and the systemic bioavailability of acetaminophen in dogs.
Sagara K; Mizuta H; Ohshiko M; Shibata M; Haga K
Pharm Res; 1995 Apr; 12(4):594-8. PubMed ID: 7596997
[TBL] [Abstract][Full Text] [Related]
6. [Determination of small intestinal transit time in beagle dogs using salicylazosulfapyridine].
Mizuta H; Kawazoe Y; Haga K; Ogawa K; Yokobe T
Yakugaku Zasshi; 1989 Oct; 109(10):760-5. PubMed ID: 2576061
[TBL] [Abstract][Full Text] [Related]
7. Using pharmacokinetic modeling to determine the effect of drug and food on gastrointestinal transit in dogs.
Sjödin L; Visser S; Al-Saffar A
J Pharmacol Toxicol Methods; 2011; 64(1):42-52. PubMed ID: 21596146
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal transit monitoring and absorption of controlled-release pellets of diltiazem.
Rahman NU; Yuen KH; Woei WJ
Pharm Dev Technol; 2005; 10(3):371-9. PubMed ID: 16176017
[TBL] [Abstract][Full Text] [Related]
9. Effect of Food Status on the Gastrointestinal Transit of Amphotericin B-Containing Solid Lipid Nanoparticles in Rats.
Amekyeh H; Billa N; Yuen KH; Lim SC
AAPS PharmSciTech; 2016 Oct; 17(5):1060-6. PubMed ID: 26511938
[TBL] [Abstract][Full Text] [Related]
10. Effect of food on gastrointestinal transit of liquids in cynomolgus monkeys.
Kondo H; Watanabe T; Yokohama S; Watanabe J
Biopharm Drug Dispos; 2003 May; 24(4):141-51. PubMed ID: 12698497
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal transit of liquids in unfed cynomolgus monkeys.
Kondo H; Takahashi Y; Watanabe T; Yokohama S; Watanabe J
Biopharm Drug Dispos; 2003 Apr; 24(3):131-40. PubMed ID: 12673671
[TBL] [Abstract][Full Text] [Related]
12. The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept.
Hsu FH; Prueksaritanont T; Lee MG; Chiou WL
J Pharmacokinet Biopharm; 1987 Aug; 15(4):369-86. PubMed ID: 3681665
[TBL] [Abstract][Full Text] [Related]
13. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit.
Kellow JE; Borody TJ; Phillips SF; Haddad AC; Brown ML
Gastroenterology; 1986 Aug; 91(2):396-400. PubMed ID: 2873075
[TBL] [Abstract][Full Text] [Related]
14. Effects of codeine on the agitating force and gastrointestinal transit time in dogs, for use in drug absorption studies.
Katori N; Aoyagi N; Kojima S
Biol Pharm Bull; 1998 Apr; 21(4):418-20. PubMed ID: 9586586
[TBL] [Abstract][Full Text] [Related]
15. Effects of atropine and loperamide on the agitating force and GI transit time in dogs in drug absorption studies.
Katori N; Aoyagi N; Kojima S
Biol Pharm Bull; 1996 Oct; 19(10):1338-40. PubMed ID: 8913508
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of small bowel transit time in dogs with acetaminophen and indocyanine green].
Yamaki K; Manabe T; Yamamoto M; Tobe T; Kobayashi Y; Mitani T; Kurono M
Nihon Shokakibyo Gakkai Zasshi; 1992 Jan; 89(1):36-41. PubMed ID: 1560595
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.
Sawamoto T; Haruta S; Kurosaki Y; Higaki K; Kimura T
J Pharm Pharmacol; 1997 Apr; 49(4):450-7. PubMed ID: 9232547
[TBL] [Abstract][Full Text] [Related]
19. Apparent dose-dependent absorption of chlorothiazide in dogs.
Resetarits DE; Bates TR
J Pharmacokinet Biopharm; 1979 Oct; 7(5):463-70. PubMed ID: 43383
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gastrointestinal drug absorption in cynomolgus monkeys.
Takahashi M; Washio T; Suzuki N; Igeta K; Fujii Y; Hayashi M; Shirasaka Y; Yamashita S
Mol Pharm; 2008; 5(2):340-8. PubMed ID: 18247527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
